Bcl-2 and p53 expressions in large-cell lymphoma: No correlation with survival

被引：0
|
作者：
Lee, JH
Kim, SY
Yoon, TY
Cho, KS
Yang, MH
Lee, S
Lee, SS
Ro, JY
机构：
[1] KYUNG HEE UNIV,SCH MED,DEPT INTERNAL MED,SEOUL 130702,SOUTH KOREA
[2] KYUNG HEE UNIV,SCH MED,DEPT PREVENT MED,SEOUL 130702,SOUTH KOREA
[3] KEIMYUNG UNIV,SCH MED,DEPT PATHOL,TAEGU,SOUTH KOREA
[4] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77030
来源：
ONCOLOGY REPORTS | 1997年 / 4卷 / 02期
关键词：
bcl-2; p53; large-cell lymphoma; survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Bcl-2 and p53 regulate apoptosis in a see-saw fashion and are expressed abnormally in a variety of malignant tumors. We investigated the frequency and prognostic significance of both bcl-2 and p53 expression in 31 large-cell lymphomas. Immunoreaction of bcl-2 and p53 was found in 74% (23/31) and 65% (20/31) of large-cell lymphomas, respectively. Overall survival was not significantly associated with immunoreactivity for either bcl-2 or p53. Frequent association with both p53 and bcl-2 in large-cell lymphomas confirms the existence of a multistep genetic deregulation in lymphomagenesis, but their clinical significance remains to be elucidated in a larger study.
引用
收藏
页码：413 / 417
页数：5
相关论文
共 50 条
  • [21] EXPRESSION ANALYSIS OF P53, BCL-2 AND CYCLIND1 IN DIFFUSE LARGE B CELL LYMPHOMA PATIENTS
    Xu, Zhiying
    Liu, Ming
    Lin, Lejun
    ACTA MEDICA MEDITERRANEA, 2019, 35 (02): : 819 - 823
  • [22] bcl-2 and p53 protein expression in non-small cell lung cancers: Correlation with survival time
    Ohsaki, Y
    Toyoshima, E
    Fujiuchi, S
    Matsui, H
    Hirata, S
    Miyokawa, N
    Kubo, Y
    Kikuchi, K
    CLINICAL CANCER RESEARCH, 1996, 2 (05) : 915 - 920
  • [23] A correlation between BCL-2 modifying factor, p53 and livin gene expressions in cancer colon patients
    Badr, Eman A. E.
    Assar, Mohamed F. A.
    Eltorgoman, Abdel Monem A.
    Labeeb, Azza Zaghlol
    Breaka, Gehad A.
    Elkhouly, Enas A.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2020, 22
  • [24] A correlation between BCL-2 modifying factor, p53 and livin gene expressions in cancer colon patients
    Elkhouly, E.
    Badr, E.
    Assar, M.
    Altorgoman, A.
    Iabeeb, A.
    Bereka, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S102 - S102
  • [25] bcl-2 and p53 in endometrial adenocarcinoma
    Taskin, M
    Lallas, TA
    Barber, HRK
    Shevchuk, MM
    MODERN PATHOLOGY, 1997, 10 (07) : 728 - 734
  • [26] Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma
    Nguyen, PL
    Zukerberg, LR
    Benedict, WF
    Harris, NL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (05) : 538 - 543
  • [27] Examination of bcl-2 and p53 expressions and apoptotic index by TUNEL method in psoriasis
    Gunduz, Kamer
    Demireli, Peyker
    Vatansever, Seda
    Inanir, Isil
    JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (12) : 788 - 792
  • [28] Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice
    Imam, SZ
    Itzhak, Y
    Cadet, JL
    Islam, F
    Slikker, W
    Ali, SF
    MOLECULAR BRAIN RESEARCH, 2001, 91 (1-2): : 174 - 178
  • [29] Expression of p53 and bcl-2 in cholangiocarcinomas
    Arora, DS
    Wyatt, JI
    JOURNAL OF PATHOLOGY, 1997, 182 : A35 - A35
  • [30] P53 AND BCL-2 EXPRESSION IN HIGH-GRADE B-CELL LYMPHOMAS - CORRELATION WITH SURVIVAL-TIME
    PIRIS, MA
    PEZELLA, F
    MARTINEZMONTERO, JC
    ORRADRE, JL
    VILLUENDAS, R
    SANCHEZBEATO, M
    CUENA, R
    CRUZ, MA
    MARTINEZ, B
    GARRIDO, MC
    GATTER, K
    AIELLO, A
    DELIA, D
    GIARDINI, R
    RILKE, F
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 337 - 341
12345